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Dear Editors,
We read with great interest the excellent article by Schin-
welski et al. [1]. The authors described two patients with 
Parkinson’s Disease (PD) with implanted deep brain stimu-
lation (DBS) who required radiation therapy (RT) due to 
different malignancies. 
Both patients were in their sixties and had been diagno-
sed with PD in their forties. At the time of qualification for 
DBS, the first patient was diagnosed with prostate cancer 
during hormonotherapy, stable on urological examination 
and biochemical markers (PSA - prostate specific antigen). 
However, a year after diagnosis, the same patient developed 
brain metastases, a distinctly unusual site for metastatic pro-
state cancer. RT (to pelvis and brain) did not cause damage 
to the DBS system; however, due to disease progression and 
urosepsis, the patient died at the age of 67. 
The second patient was treated with DBS after a diagnosis 
of breast cancer. Eight years after DBS therapy, she had a re-
currence of breast cancer and RT was conducted. No impact 
on the DBS system was observed. The DBS systems were active 
during all RT procedures performed in both patients [1].
The authors also discussed previously reported cases of 
RT use in patients treated with DBS [1]. While DBS of the 
subthalamic nucleus and globus pallidus internus was appro-
ved in 2002 for PD therapy, only four other cases of RT use in 
this context have been reported [2]. Mazdai et al. [3] described 
a patient treated with DBS for severe PD who underwent RT 
to the head and neck. Another study reported a patient with 
bilateral DBS who underwent RT for a left upper lung tumour 
[4]. The irradiated areas in the two other cases were brain 
metastases [5, 6]. In all cases described, no negative impact 
on DBS system was observed. 
The conclusion drawn from this experience, albeit based 
on rare cases, is that RT appears safe in the context of DBS. 
More studies have been performed with pacemakers and 
implantable cardioverter defibrillators (PM/ICD). Patients with 
PM/ICD undergoing RT do not require supplementary device 
evaluations in PM/ICD clinic as per manufacturers’ instructions 
[7]. As the impact of RT on such devices is more dependent on 
beam energy than on a total dose of radiation, limiting photon 
beam energy to 10 MV or less is recommended where possible. 
The frequency of PM/ICD malfunction is about 3% and consists 
mainly of device resets, rarely requiring replacement [8].
Between 1995 and 2020, more than 2,000 DBS procedures 
were performed in the Departments of Neurology and Neuro-
surgery at the Mayo Clinic in Jacksonville, Florida. 
We would like to present a case report of a patient treated with 
DBS who had cancer and for whom RT was considered as one 
treatment option. Our patient, a 68-year-old man, had contended 
with PD symptoms for more than 20 years, with the condition 
having been heralded by resting tremor in the left hand. Bilateral 
DBS was performed to combat motor fluctuations characterised 
by intolerable levodopa-induced dyskinesia, with good response. 
Four years after DBS therapy, the patient developed an enlarged 
lymph node near the clavicle, which was subsequently resected 
with histopathology confirming non-Hodgkin’s lymphoma. Dif-
ferent treatment options were considered, including RT; however, 
the patient was initially treated with chemotherapy.
This case, we believe, is the first reported instance of 
non-Hodgkin’s lymphoma in a patient treated with DBS. 
We believe that RT can be considered in our patient, and in 
others similarly affected. The topic of DBS and the incidence 
of cancer and subsequent implications for therapy is relatively 
unchartered, and requires further study.
Acknowledgements: L.M. is supported by the Polish National 
Agency for Academic Exchange Iwanowska’s Fellowship PPN/
IWA/2018/1/00006/U/00001/01.
Conflict of interest: None
2Neurologia i Neurochirurgia Polska 2020, vol. 54
www.journals.viamedica.pl/neurologia_neurochirurgia_polska
References
1. Schinwelski MJ, Dulski J, Łuczak W, et al. Radiation therapy in patients 
with implanted deep brain stimulation. Neurol Neurochir Pol. 2020
[Epub ahead of print], doi: 10.5603/PJNNS.a2020.0033, indexed 
in Pubmed: 32285432.
2. Smilowska K, Bloem BR, Esselink RAJ, et al. Keep calm and beam 
on? Unmet needs in radiotherapy and deep brain stimulation. Par-
kinsonism Relat Disord. 2020; 71: 15–16, doi: 10.1016/j.parkrel-
dis.2020.01.005, indexed in Pubmed: 31955127.
3. Mazdai G, Stewart DP, Hounsell AR. Radical radiation therapy in a pa-
tient with head and neck cancer and severe Parkinson’s disease.
Clin Oncol (R Coll Radiol). 2006; 18(1): 82–84, doi: 10.1016/j.
clon.2005.09.009, indexed in Pubmed: 16477925.
4. Borkenhagen JF, Morris ZS, Hoberg JR, et al. Delivery of definitive dose 
external beam radiation in close proximity to an implanted deep brain 
stimulator. Pract Radiat Oncol. 2014; 4(5): 294–297, doi: 10.1016/j.
prro.2013.10.003, indexed in Pubmed: 25194097.
5. Guy JB, Levy A, Malkoun N, et al. Preventing radiotherapy-induced 
side effects on deep brain stimulators: the need for a multidisci-
plinary management. Br J Neurosurg. 2014; 28(1): 107–109, doi: 
10.3109/02688697.2013.801395, indexed in Pubmed:
23692069.
6. Kotecha R, Berriochoa CA, Murphy ES, et al. Report of whole-bra-
in radiation therapy in a patient with an implanted deep brain sti-
mulator: important neurosurgical considerations and radiothera-
py practice principles. J Neurosurg. 2016; 124(4): 966–970, doi: 
10.3171/2015.2.JNS142951, indexed in Pubmed: 26315009.
7. Munshi A, Agarwal JP, Pandey KC. Cancer patients with cardiac pace-
makers needing radiation treatment: a systematic review. J Cancer Res 
Ther. 2013; 9(2): 193–198, doi: 10.4103/0973-1482.113348, 
indexed in Pubmed: 23771357.
8. Zaremba T, Jakobsen AR, Søgaard M, et al. Radiotherapy in patients 
with pacemakers and implantable cardioverter defibrillators: a litera-
ture review. Europace. 2016; 18(4): 479–491, doi: 10.1093/euro-
pace/euv135, indexed in Pubmed: 26041870.
